BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ashton JJ, Boukas K, Davies J, Stafford IS, Vallejo AF, Haggarty R, Coelho TAF, Batra A, Afzal NA, Vadgama B, Williams AP, Beattie RM, Polak ME, Ennis S. Ileal Transcriptomic Analysis in Paediatric Crohn's Disease Reveals IL17- and NOD-signalling Expression Signatures in Treatment-naïve Patients and Identifies Epithelial Cells Driving Differentially Expressed Genes. J Crohns Colitis 2021;15:774-86. [PMID: 33232439 DOI: 10.1093/ecco-jcc/jjaa236] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Ashton JJ, Ennis S, Beattie RM. Infliximab at diagnosis: moving towards personalisation in paediatric inflammatory bowel disease. Gut 2022;71:2-3. [PMID: 33722861 DOI: 10.1136/gutjnl-2021-324214] [Reference Citation Analysis]
2 Ashton JJ, Boukas K, Stafford IS, Cheng G, Haggarty R, Coelho TAF, Batra A, Afzal NA, Williams AP, Polak ME, Beattie RM, Ennis S. Deleterious Genetic Variation Across the NOD Signaling Pathway Is Associated With Reduced NFKB Signaling Transcription and Upregulation of Alternative Inflammatory Transcripts in Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis 2022:izab318. [PMID: 34978330 DOI: 10.1093/ibd/izab318] [Reference Citation Analysis]
3 Shen L, Lan L, Zhu T, Chen H, Gu H, Wang C, Chen Y, Wang M, Tu H, Enghard P, Jiang H, Chen J. Identification and Validation of IFI44 as Key Biomarker in Lupus Nephritis. Front Med (Lausanne) 2021;8:762848. [PMID: 34760904 DOI: 10.3389/fmed.2021.762848] [Reference Citation Analysis]